Randomized trial: Dapagliflozin in patients with chronic kidney disease
25 Sep, 2020 | 02:34h | UTCDapagliflozin in Patients with Chronic Kidney Disease – New England Journal of Medicine (free for a limited period)
Commentary: Dapagliflozin Cuts Renal Risks in Patients with CKD, Regardless of Diabetes Status – NEJM Journal Watch